Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_assertion type Assertion NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_head.
- NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_assertion description "[A case-control design comprising 884 type 2 diabetic patients and 513 control subjects living in the East-Center of Tunisia was used to analyze the contribution to T2D of the following SNPs: E23K in KCNJ11/Kir6.2, K121Q in ENPP1, the -30G/A variant in the pancreatic beta-cell specific promoter of Glucokinase, rs7903146 in TCF7L2 encoding transcription factor 7-like2, and rs7923837 in HHEX encoding the homeobox, hematopoietically expressed transcription factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_provenance.
- NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_assertion evidence source_evidence_literature NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_provenance.
- NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_assertion SIO_000772 19368707 NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_provenance.
- NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_assertion wasDerivedFrom gad-20150221 NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_provenance.
- NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_assertion wasGeneratedBy ECO_0000203 NP53895.RAd4iW16JeQJ1DURP_4_9MPi6nWRkzFT0ooFska2STvrM130_provenance.